{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:01:34Z","timestamp":1767909694670,"version":"3.49.0"},"reference-count":21,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Comprehensive genomic profiling has demonstrated that approximately 20% of pancreatic carcinomas with acinar differentiation harbor potentially targetable BRAF fusions that activate the MAPK pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives.\u2014<\/jats:title>\n                    <jats:p>To validate the above finding by BRAF break-apart fluorescence in situ hybridization (FISH) in a large series of pure acinar cell carcinomas (ACCs), evaluate tumors for the presence of BRAF V600E mutations, and compare clinicopathologic features of tumors with BRAF rearrangements with those without.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Thirty cases of pure ACC and 6 cases of mixed acinar-neuroendocrine carcinoma (ACC-NEC) were retrieved. A break-apart FISH probe was used to detect BRAF rearrangements. Immunohistochemistry for BRAF V600E was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>BRAF rearrangements by FISH were found in 6 of 36 cases (17%), 5 of which were pure ACC and 1 was a mixed ACC-NEC. Follow-up was available in 29 of 36 cases (81%). The median survival was 22 months for BRAF-rearranged cases and 16 months for BRAF-intact cases; the 2-year overall survival was 50% for BRAF-rearranged cases and 35% for BRAF-intact cases. No significant clinicopathologic differences were identified in cases with BRAF rearrangement compared with those without BRAF rearrangement. BRAF V600E mutation was identified in 2 of 34 cases (6%), both of which were pure ACC and were BRAF-intact by FISH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>This study supports the finding that BRAF rearrangements are present in approximately 20% of cases and identified BRAF V600E mutations in approximately 5% of cases. These cases may benefit from targeted therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2020-0739-oa","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T22:32:13Z","timestamp":1633818733000},"page":"840-845","source":"Crossref","is-referenced-by-count":8,"title":["<i>BRAF<\/i>\n                    Rearrangements and\n                    <i>BRAF<\/i>\n                    V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation"],"prefix":"10.5858","volume":"146","author":[{"given":"Toshi","family":"Ghosh","sequence":"first","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene","family":"Knutson","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Kloft-Nelson","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Jenkins","sequence":"additional","affiliation":[{"name":"From the Department of Health Sciences Research (Jenkins), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taofic","family":"Mounajjed","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Said","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"La Rosa","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland (La Rosa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Vanoli","sequence":"additional","affiliation":[{"name":"From the Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia, and IRCCS San Matteo Hospital, Pavia, Italy (Vanoli)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Sessa","sequence":"additional","affiliation":[{"name":"From the Anatomic Pathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy (Sessa)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita V.","family":"Naini","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of California, Los Angeles (Naini)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bellizzi","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Iowa, Iowa City (Bellizzi)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Kerr","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rondell P.","family":"Graham","sequence":"additional","affiliation":[{"name":"From the Department of Laboratory Medicine and Pathology (Ghosh, Greipp, Knutson, Kloft-Nelson, Mounajjed, Said, Zhang, Kerr, Graham), Mayo Clinic, Rochester, Minnesota."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"2022092919530954400_i1543-2165-146-7-840-b01","doi-asserted-by":"crossref","unstructured":"Klimstra\n              DS,\n            \n            \n              Adsay\n              V.\n            \n          \n          Acinar neoplasms of the pancreas-a summary of 25 years of research.\n\t\t\t\t\tSemin Diagn Pathol.\n\t\t\t\t\t2016;\n\t\t\t\t\t33(5):\n\t\t\t\t\t307\u2013\n\t\t\t\t\t318.\n\t\t\t\t\tdoi:10.1053\/j.semdp.2016.05.009","DOI":"10.1053\/j.semdp.2016.05.009"},{"key":"2022092919530954400_i1543-2165-146-7-840-b02","doi-asserted-by":"crossref","unstructured":"Klimstra\n              DS,\n            \n            \n              Heffess\n              CS,\n            \n            \n              Oertel\n              JE,\n            \n            \n              Rosai\n              J.\n            \n          \n          Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t1992;\n\t\t\t\t\t16(9):\n\t\t\t\t\t815\u2013\n\t\t\t\t\t837.\n\t\t\t\t\tdoi:10.1097\/00000478-199209000-00001","DOI":"10.1097\/00000478-199209000-00001"},{"key":"2022092919530954400_i1543-2165-146-7-840-b03","doi-asserted-by":"crossref","unstructured":"La Rosa\n              S,\n            \n            \n              Adsay\n              V,\n            \n            \n              Albarello\n              L,\n            \n            et al.\n          \n          Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2012;\n\t\t\t\t\t36(12):\n\t\t\t\t\t1782\u2013\n\t\t\t\t\t1795.\n\t\t\t\t\tdoi:10.1097\/PAS.0b013e318263209d","DOI":"10.1097\/PAS.0b013e318263209d"},{"key":"2022092919530954400_i1543-2165-146-7-840-b04","doi-asserted-by":"crossref","unstructured":"Klimstra\n              DS.\n            \n          \n          Nonductal neoplasms of the pancreas.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2007;\n\t\t\t\t\t20Suppl 1:\n\t\t\t\t\tS94\u2013\n\t\t\t\t\tS112.\n\t\t\t\t\tdoi:10.1038\/modpathol.3800686","DOI":"10.1038\/modpathol.3800686"},{"key":"2022092919530954400_i1543-2165-146-7-840-b05","doi-asserted-by":"crossref","unstructured":"Hruban\n              RH,\n            \n            \n              Ali\n              SZ.\n            \n          \n          Acinar cell carcinoma.\n\t\t\t\t\tIn:Iacobuzio-DonahueCA,ed.Gastrointestinal and Liver Pathology. 2nd edition.\n\t\t\t\t\tAmsterdam, the Netherlands; Elsevier.2012:\n\t\t\t\t\t514\u2013\n\t\t\t\t\t556.","DOI":"10.1016\/B978-1-4377-0925-4.00026-2"},{"key":"2022092919530954400_i1543-2165-146-7-840-b06","doi-asserted-by":"crossref","unstructured":"La Rosa\n              S,\n            \n            \n              Sessa\n              F,\n            \n            \n              Capella\n              C.\n            \n          \n          Acinar cell carcinoma of the pancreas: overview of clinicopathologic features and insights into the molecular pathology.\n\t\t\t\t\tFront Med (Lausanne).\n\t\t\t\t\t2015;\n\t\t\t\t\t2:\n\t\t\t\t\t41.\n\t\t\t\t\tdoi:10.3389\/fmed.2015.00041","DOI":"10.3389\/fmed.2015.00041"},{"key":"2022092919530954400_i1543-2165-146-7-840-b07","doi-asserted-by":"crossref","unstructured":"J\u00e4kel\n              C,\n            \n            \n              Bergmann\n              F,\n            \n            \n              Toth\n              R,\n            \n            et al.\n          \n          Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability.\n\t\t\t\t\tNat Commun.\n\t\t\t\t\t2017;\n\t\t\t\t\t8(1):\n\t\t\t\t\t1323.\n\t\t\t\t\tdoi:10.1038\/s41467-017-01118-x","DOI":"10.1038\/s41467-017-01118-x"},{"key":"2022092919530954400_i1543-2165-146-7-840-b08","doi-asserted-by":"crossref","unstructured":"Chmielecki\n              J,\n            \n            \n              Hutchinson\n              KE,\n            \n            \n              Frampton\n              GM,\n            \n            et al.\n          \n          Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes [published correction appears in Cancer Discov.\n\t\t\t\t\t2015;\n\t\t\t\t\t5(3):332].Cancer Discov.\n\t\t\t\t\t2014;\n\t\t\t\t\t4(12):\n\t\t\t\t\t1398\u2013\n\t\t\t\t\t1405.\n\t\t\t\t\tdoi:10.1158\/2159-8290.CD-14-0617","DOI":"10.1158\/2159-8290.CD-14-0617"},{"key":"2022092919530954400_i1543-2165-146-7-840-b09","doi-asserted-by":"crossref","unstructured":"Prall\n              OWJ,\n            \n            \n              Nastevski\n              V,\n            \n            \n              Xu\n              H,\n            \n            et al.\n          \n          RAF1 rearrangements are common in pancreatic acinar cell carcinomas.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2020;\n\t\t\t\t\t33(9):\n\t\t\t\t\t1811\u2013\n\t\t\t\t\t1821.\n\t\t\t\t\tdoi:10.1038\/s41379-020-0545-9","DOI":"10.1038\/s41379-020-0545-9"},{"key":"2022092919530954400_i1543-2165-146-7-840-b10","doi-asserted-by":"crossref","unstructured":"Peterson\n              LM,\n            \n            \n              Kipp\n              BR,\n            \n            \n              Halling\n              KC,\n            \n            et al.\n          \n          Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.\n\t\t\t\t\tInt J Gynecol Pathol.\n\t\t\t\t\t2012;\n\t\t\t\t\t31(3):\n\t\t\t\t\t195\u2013\n\t\t\t\t\t205.\n\t\t\t\t\tdoi:10.1097\/PGP.0b013e318231fc51","DOI":"10.1097\/PGP.0b013e318231fc51"},{"key":"2022092919530954400_i1543-2165-146-7-840-b11","doi-asserted-by":"crossref","unstructured":"Graham\n              RP,\n            \n            \n              Jin\n              L,\n            \n            \n              Knutson\n              DL,\n            \n            et al.\n          \n          DNAJB1-PRKACA is specific for fibrolamellar carcinoma.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2015;\n\t\t\t\t\t28(6):\n\t\t\t\t\t822\u2013\n\t\t\t\t\t829.\n\t\t\t\t\tdoi:10.1038\/modpathol.2015.4","DOI":"10.1038\/modpathol.2015.4"},{"key":"2022092919530954400_i1543-2165-146-7-840-b12","doi-asserted-by":"crossref","unstructured":"Chou\n              A,\n            \n            \n              Kim\n              Y,\n            \n            \n              Samra\n              JS,\n            \n            \n              Pajic\n              M,\n            \n            \n              Gill\n              AJ.\n            \n          \n          BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma.\n\t\t\t\t\tPathology.\n\t\t\t\t\t2018;\n\t\t\t\t\t50(3):\n\t\t\t\t\t345\u2013\n\t\t\t\t\t348.\n\t\t\t\t\tdoi:10.1016\/j.pathol.2017.09.027","DOI":"10.1016\/j.pathol.2017.09.027"},{"key":"2022092919530954400_i1543-2165-146-7-840-b13","doi-asserted-by":"crossref","unstructured":"Wang\n              L,\n            \n            \n              Basturk\n              O,\n            \n            \n              Wang\n              J,\n            \n            et al.\n          \n          A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2018;\n\t\t\t\t\t31(1):\n\t\t\t\t\t132\u2013\n\t\t\t\t\t140.\n\t\t\t\t\tdoi:10.1038\/modpathol.2017.106","DOI":"10.1038\/modpathol.2017.106"},{"key":"2022092919530954400_i1543-2165-146-7-840-b14","doi-asserted-by":"crossref","unstructured":"Jiao\n              Y,\n            \n            \n              Yonescu\n              R,\n            \n            \n              Offerhaus\n              GJ,\n            \n            et al.\n          \n          Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.\n\t\t\t\t\tJ Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t232(4):\n\t\t\t\t\t428\u2013\n\t\t\t\t\t435.\n\t\t\t\t\tdoi:10.1002\/path.4310","DOI":"10.1002\/path.4310"},{"key":"2022092919530954400_i1543-2165-146-7-840-b15","doi-asserted-by":"crossref","unstructured":"Furukawa\n              T,\n            \n            \n              Sakamoto\n              H,\n            \n            \n              Takeuchi\n              S,\n            \n            et al.\n          \n          Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.\n\t\t\t\t\tSci Rep.\n\t\t\t\t\t2015;\n\t\t\t\t\t5:\n\t\t\t\t\t8829.\n\t\t\t\t\tdoi:10.1038\/srep08829","DOI":"10.1038\/srep08829"},{"key":"2022092919530954400_i1543-2165-146-7-840-b16","doi-asserted-by":"crossref","unstructured":"Bergmann\n              F,\n            \n            \n              Aulmann\n              S,\n            \n            \n              Sipos\n              B,\n            \n            et al.\n          \n          Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases.\n\t\t\t\t\tVirchows Arch.\n\t\t\t\t\t2014;\n\t\t\t\t\t465(6):\n\t\t\t\t\t661\u2013\n\t\t\t\t\t672.\n\t\t\t\t\tdoi:10.1007\/s00428-014-1657-8","DOI":"10.1007\/s00428-014-1657-8"},{"key":"2022092919530954400_i1543-2165-146-7-840-b17","doi-asserted-by":"crossref","unstructured":"Ross\n              JS,\n            \n            \n              Wang\n              K,\n            \n            \n              Chmielecki\n              J,\n            \n            et al.\n          \n          The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.\n\t\t\t\t\tInt J Cancer.\n\t\t\t\t\t2016;\n\t\t\t\t\t138(4):\n\t\t\t\t\t881\u2013\n\t\t\t\t\t890.\n\t\t\t\t\tdoi:10.1002\/ijc.29825","DOI":"10.1002\/ijc.29825"},{"key":"2022092919530954400_i1543-2165-146-7-840-b18","doi-asserted-by":"crossref","unstructured":"Flaherty\n              KT,\n            \n            \n              Puzanov\n              I,\n            \n            \n              Kim\n              KB,\n            \n            et al.\n          \n          Inhibition of mutated, activated BRAF in metastatic melanoma.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2010;\n\t\t\t\t\t363(9):\n\t\t\t\t\t809\u2013\n\t\t\t\t\t819.\n\t\t\t\t\tdoi:10.1056\/NEJMoa1002011","DOI":"10.1056\/NEJMoa1002011"},{"key":"2022092919530954400_i1543-2165-146-7-840-b19","doi-asserted-by":"crossref","unstructured":"Tiacci\n              E,\n            \n            \n              Park\n              JH,\n            \n            \n              De Carolis\n              L,\n            \n            et al.\n          \n          Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2015;\n\t\t\t\t\t373(18):\n\t\t\t\t\t1733\u2013\n\t\t\t\t\t1747.\n\t\t\t\t\tdoi:10.1056\/NEJMoa1506583","DOI":"10.1056\/NEJMoa1506583"},{"key":"2022092919530954400_i1543-2165-146-7-840-b20","doi-asserted-by":"crossref","unstructured":"Kopetz\n              S,\n            \n            \n              Grothey\n              A,\n            \n            \n              Yaeger\n              R,\n            \n            et al.\n          \n          Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2019;\n\t\t\t\t\t381(17):\n\t\t\t\t\t1632\u2013\n\t\t\t\t\t1643.\n\t\t\t\t\tdoi:10.1056\/NEJMoa1908075","DOI":"10.1056\/NEJMoa1908075"},{"key":"2022092919530954400_i1543-2165-146-7-840-b21","doi-asserted-by":"crossref","unstructured":"Long\n              GV,\n            \n            \n              Stroyakovskiy\n              D,\n            \n            \n              Gogas\n              H,\n            \n            et al.\n          \n          Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2014;\n\t\t\t\t\t371(20):\n\t\t\t\t\t1877\u2013\n\t\t\t\t\t1888.\n\t\t\t\t\tdoi:10.1056\/NEJMoa1406037","DOI":"10.1056\/NEJMoa1406037"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/146\/7\/840\/3126462\/i1543-2165-146-7-840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/146\/7\/840\/3126462\/i1543-2165-146-7-840.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:39:02Z","timestamp":1764790742000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/146\/7\/article-p840.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,10,6]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2020-0739-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,6]]}}}